{"version":"1.0","type":"link","title":"Cost-Effectiveness Analysis of Second-Line Lisocabtagene Maraleucel in the Treatment of Refractory or Relapsed Large B-Cell Lymphoma.","author_name":"Thieblemont C 외","author_url":"https://prs-insight.online/author/Thieblemont%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/162010","thumbnail_width":1200,"thumbnail_height":630}